About
Technology
Issues
FAQ
Links
Official Page
Trastuzumab deruxtecan and other HER2-targeting agents for the treatment of HER2-positive gastric cancer
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.